πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 591 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 11890330

Endolysins active against Bacillus bacteria, pharmaceutical compositions, and methods rela

United States of America as represented by the Secretary of the Air Force Β· Granted Tue Feb 06 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11883468

Compositions and methods to suppress tumor growth in bone, prevent cachectic muscle loss,

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Jan 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11882920

Systems, devices and methods for styling hair

MIRAKEL TECHNOLOGIES, INC. Β· Granted Tue Jan 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11865125

APKC inhibitors and methods of treating a neurodegenerative disease or disorder

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Jan 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11865171

Foot-and-mouth disease vaccine

United States of America as represented by the Secretary of the Air Force Β· Granted Tue Jan 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11866503

Methods for treating inflammatory conditions of the airway or lungs by administering antag

REGENERON PHARMACEUTICALS, INC. Β· Granted Tue Jan 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11857528

Methods of providing solriamfetol therapy to subjects with impaired renal function

AXSOME MALTA LTD. Β· Granted Tue Jan 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11857550

Benzathine analogs

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Jan 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11850259

Methods of treating viral infections affecting the respiratory tract using topically admin

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Dec 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11850226

Methods of providing solriamfetol therapy to subjects with impaired renal function

AXSOME MALTA LTD. Β· Granted Tue Dec 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11850228

Methods of providing solriamfetol therapy to subjects with impaired renal function

AXSOME MALTA LTD. Β· Granted Tue Dec 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11850227

Methods of providing solriamfetol therapy to subjects with impaired renal function

AXSOME MALTA LTD. Β· Granted Tue Dec 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11844779

PKC-Delta-I inhibitor formulations and uses thereof

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Dec 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11844874

Lyophilized polymer scaffold compositions, processes for preparation and use in anabolic w

ORTHO REGENERATIVE TECHNOLOGIES INC. Β· Granted Tue Dec 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11839598

Methods of providing solriamfetol therapy to subjects with impaired renal function

AXSOME MALTA LTD. Β· Granted Tue Dec 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11839649

Compositions comprising recombinant probiotic bacteria and methods of use thereof

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Dec 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11839629

Methods and compositions to modulate hair growth

SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE Β· Granted Tue Dec 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11839599

Methods of providing solriamfetol therapy to subjects with impaired renal function

AXSOME MALTA LTD. Β· Granted Tue Dec 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11813485

Systems and methods for histotripsy immunosensitization

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Nov 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11806389

Compositions and methods for treating central nervous system injury

The United States Government as Represented by The Department of Veteran Affairs Β· Granted Tue Nov 07 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11801241

Muscarinic M2 receptor blockade to delay or prevent onset of progressive memory decline

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Oct 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11793860

Vault complexes for cytokine delivery

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Oct 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11787840

Compositions and methods for treating and preventing autoimmune induced cardiac long QT sy

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Oct 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11786540

Gliflozins and a method for their delivery during resuscitation from cardiac arrest to imp

THE UNITED STATES AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS Β· Granted Tue Oct 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted